SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2021 / Cilt: 69 - Sayı: 4

Efficacy of pulmonary rehabilitation on patients with non-cystic bronchiectasis according to disease severity

Sami DENİZ
Hülya DOĞAN ŞAHİN
Ahmet Emin ERBAYCU
Pages
449–457
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thus, appropriate bronchiectasis patients should be referred to PR program regardless of disease severity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Efficacy of pulmonary rehabilitation on patients with non-cystic bronchiectasis according to disease severity Introduction: The European Respiratory Society guidelines support pulmonary rehabilitation (PR) in bronchiectasis through high-quality evidence.
📊
Key Findings & Data:All patients underwent an 8-week PR program.
💡
Conclusion & Impact:Thus, appropriate bronchiectasis patients should be referred to PR program regardless of disease severity
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Efficacy of pulmonary rehabilitation on patients with non-cystic bronchiectasis according to disease severity Introduction: The European Respiratory Society guidelines support pulmonary rehabilitation (PR) in bronchiectasis through high-quality evidence. This study aimed to evaluate the efficacy of PR on bronchiectasis patients according to disease severity assessed by the Bronchiectasis Severity Index (BSI). Materials and Methods: This prospective study included patients with stable bronchiectasis. Demographic data of all patients were questioned. All patients underwent an 8-week PR program. The patients were grouped into three according to disease severity (mild, moderate and severe) based on their BSI scores. The following parameters were evaluated at baseline (pre-PR) and after PR (post-PR): pulmonary function test results, carbon monoxide diffusion capacity, body mass index, exercise capacity (6-minute walking test), quality of life (QoL; St. George’s Respiratory Questionnaire), and Hospital Anxiety and Depression scores. Results: The study included 69 patients (55 males; mean age, 62.6 ± 9 years). After PR, the patients were observed to have significantly improved QoL and exercise capacity (p 0.05) in the groups. Conclusion: PR increases exercise capacity and QoL in bronchiectasis patients, and its efficacy does not differ according to disease severity. Thus, appropriate bronchiectasis patients should be referred to PR program regardless of disease severity

🔖

Cite This Article

DENİZ, S., ŞAHİN, H. D., ERBAYCU, A. E. (2021). Efficacy of pulmonary rehabilitation on patients with non-cystic bronchiectasis according to disease severity. Tüberküloz ve Toraks, Cilt: 69 - Sayı: 4, 449–457. https://ajindex.com/articles/417244

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J 2017; 50 (3): 1700629
  2. Chalmers JD, Aliberti S, Polverino E, Vendrell M, Crichton M, Loebinger M, et al. The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res 2016; 2 (1): 00081-2015
  3. Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med 2014; 189(5): 576-85
  4. Chalmers JD, Chotirmall SH. Bronchiectasis: new therapies and new perspectives. Lancet Respir Med 2018; 6(9): 715-26
  5. Lee AL, Button BM, Ellis S, Stirling R, Wilson JW, Holland AE, et al. Clinical determinants of the 6-Minute Walk Test in bronchiectasis. Respir Med 2009; 103(5): 780-5
  6. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/ European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188(8): e13-64. Erratum in: Am J Respir Crit Care Med 2014; 189 (12): 1570
  7. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1): 111-7
  8. Polatlı M, Yorgancıoğlu A, Aydemir Ö, Demirci NY, Kırkıl G, Naycı SA, et al. St. George solunum anketinin Türkçe geçerlilik ve güvenilirliği [Validity and reliability of Turkish version of St. George’s respiratory questionnaire]. Tuberk Toraks 2013; 61(2): 81-7
  9. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361-70
  10. Aydemir O, Guvenir T, Küey L, Kültür S. Validity and reliability of Turkish version of Hospital Anxiety and Depression Scale. Turk Psikiyatri Derg 1997: 8: 280-8. [Turkish]
  11. Zanini A, Aiello M, Adamo D, Cherubino F, Zampogna E, Sotgiu G, et al. Effects of Pulmonary Rehabilitation in Patients with Non-Cystic Fibrosis Bronchiectasis: A Retrospective Analysis of Clinical and Functional Predictors of Efficacy. Respiration 2015; 89(6): 525-33
  12. Ong HK, Lee AL, Hill CJ, Holland AE, Denehy L. Effects of pulmonary rehabilitation in bronchiectasis: A retrospective study. Chron Respir Dis 2011; 8(1): 21-30
  13. Mandal P, S